Science Corp., Another Braintech Startup Founded By Neuralink Alums, Raises $230M Series C

Artificial intelligence • Health, Wellness & Biotech • Semiconductors and 5G • Startups • Venture

Science Corp., Another Braintech Startup Founded By Neuralink Alums, Raises $230M Series C

March 5, 2026

Illustration of "clicking" on an AI brain {Dom Guzman]

Mary Ann Azevedo

, a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a $230 million Series C fundraise.

, , , and were among the investors participating in the syndicated round. With the latest financing, Science Corp. says it has now raised $489 million since its 2021 inception. The Alameda, California-based company鈥檚 most recent raise previously was led by Khosla last April.

While Science did not disclose its valuation in the announcement, it has been that the company is now valued at $1.5 billion.

The competitor is working on both a brain-implant system and a retina implant to treat eye diseases. Notably, it was founded by , a co-founder of Neuralink, and , formerly part of Neuralink’s leadership team.

Science says it acquired MEMS, or microelectromechanical systems, facility assets in North Carolina, giving it the ability to manufacture in-house chip/MEMS for neural interface devices. Many competitors outsource manufacturing, which the company noted can slow down iteration or increase cost and risk.

The company says the funding will accelerate the commercialization of its PRIMA BCI retinal implant, with the expansion of its PRIMA clinical trial program to include other retinal diseases such as Stargardt disease and retinitis pigmentosa.

Big deals for neural interface startups

Billions of venture dollars have flowed into the neural interface and brain technology space in recent years, with Neuralink being the most well-funded of the group. Last June, the -founded brain implant startup, announced a $650 million Series E funding round.

Other companies working on computer-brain interfaces have also raised significant venture backing, a review of 附近上门 data shows.

Another example is China鈥檚 , a Neuralink competitor that raised a $48 million Series B funding round in February 2025, the largest-ever funding round for a startup in the field in that country. It also raised an unknown amount of capital in December. It鈥檚 unclear how much the company raised in previous venture rounds.

Meanwhile, yet another Neuralink competitor, Austin-based , announced last June that it had performed its using its Connexus Brain-Computer Interface. Paradromics has in funding since its 2015 inception, according to 附近上门 data. Investors include , , , and.

附近上门